Talk to Alison

(866) 682 9815

Search inside this page

All regions

Free Market Research Guides to Download

Therapy Analysis & Statistics, May 2013

You might be interested in: therapeutics, biotherapeutics, therapy review, more »

» Purchase Premium Reports

1-30 of about 5 300 reports
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017

  • $ 5 995
  • Industry report
  • April 2013
  • by Global Data

OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017 Summary Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia ...

  • Industries : Therapy
Analytical Tool - Protein Kinase Inhibitors in Oncology

Analytical Tool - Protein Kinase Inhibitors in Oncology

  • $ 6 674
  • Industry report
  • April 2013
  • by Bioseeker

Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors ...

  • Industries : Therapy
Personalized Medicine Partnering Terms and Agreements

Personalized Medicine Partnering Terms and Agreements

  • $ 4 995
  • Industry report
  • April 2013
  • by Currentpartnering

Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The Personalized Medicine Partnering ...

  • Industries : Therapy
Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

  • $ 4 595
  • Industry report
  • March 2013
  • by Transparency Market Research

Peptide therapeutics is currently offering a new commercial potential to pharmaceuticals and biotechnology industry. To exploit this emerging market, large pharmaceutical and biotechnological firms are ...

  • Industries : Therapy
  • Countries : World
Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

  • $ 3 500
  • Industry report
  • April 2013
  • by GBI Research

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players Summary GBI Research, the leading ...

  • Industries : Therapy
  • Countries : India
Global Cardiac Resynchronization Therapy (CRT) Devices - Market Growth Analysis, 2009-2015

Global Cardiac Resynchronization Therapy (CRT) Devices - Market Growth Analysis, 2009-2015

  • $ 3 270
  • Industry report
  • April 2013
  • by Axis Research Mind

Global Market Watch: The broad ?health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac ...

  • Industries : Therapy
  • Countries : World, United States
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech

  • $ 2 995
  • Industry report
  • April 2013
  • by Currentpartnering

The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the clinical stage partnering deals and agreements entered ...

  • Industries : Therapy
Cancer Pain Global Clinical Trials Review, H1, 2013

Cancer Pain Global Clinical Trials Review, H1, 2013

  • $ 2 500
  • Industry report
  • April 2013
  • by Global Data

Cancer Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Cancer Pain Global Clinical Trials Review, H1, 2013" provides data on the Cancer Pain clinical trial scenario. ...

  • Industries : Therapy
  • Countries : World
Psychiatric Disorders - Pipeline Review, H1 2013

Psychiatric Disorders - Pipeline Review, H1 2013

  • $ 2 500
  • Company report
  • April 2013
  • by Global Markets Direct

Psychiatric Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Psychiatric Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Therapy
  • Countries : United States
Drug and Medication Industry: HIV / AIDS - Pipeline Review, H1 2012

Drug and Medication Industry: HIV / AIDS - Pipeline Review, H1 2012

  • $ 2 500
  • Industry report
  • February 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for HIV / AIDS, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Therapy
Therapy Industry: Alzheimer%s Disease - Pipeline Review, H1 2012

Therapy Industry: Alzheimer%s Disease - Pipeline Review, H1 2012

  • $ 2 500
  • Industry report
  • February 2013
  • by Global Markets Direct

Alzheimer's Disease - Pipeline Review, H1 2012 What's inside this report? Global Industries Direct's, 'Alzheimer's Disease - Pipeline Review, H1 2012', provides an overview of the Alzheimer's Disease ...

  • Industries : Therapy
  • Countries : United States
Therapy in United States: Hepatitis C - Pipeline Review, H1 2012

Therapy in United States: Hepatitis C - Pipeline Review, H1 2012

  • $ 2 500
  • Industry report
  • February 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Hepatitis C, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Therapy
  • Countries : United States
Therapy in United States: Melanoma - Pipeline Review, H1 2012

Therapy in United States: Melanoma - Pipeline Review, H1 2012

  • $ 2 500
  • Industry report
  • February 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Melanoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

  • Industries : Therapy
  • Countries : United States, World
Dental Pain Global Clinical Trials Review, H1, 2013

Dental Pain Global Clinical Trials Review, H1, 2013

  • $ 2 500
  • Industry report
  • February 2013
  • by Global Data

Dental Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Dental Pain Global Clinical Trials Review, H1, 2013" provides data on the Dental Pain clinical trial scenario. ...

  • Industries : Therapy
  • Countries : World
Gram-Positive Bacterial Infections - Pipeline Review, H1 2013

Gram-Positive Bacterial Infections - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

Gram-Positive Bacterial Infections - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Gram-Positive Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication's ...

  • Industries : Therapy
World Therapy: Burns - Pipeline Review, H1 2012

World Therapy: Burns - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Burns, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...

  • Industries : Therapy
  • Countries : World, United States
World Biological Therapy: Indolent Lymphoma - Pipeline Review, H1 2012

World Biological Therapy: Indolent Lymphoma - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Therapy
  • Countries : World
World Biological Therapy: Myelofibrosis - Pipeline Review, H1 2012

World Biological Therapy: Myelofibrosis - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Myelofibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Therapy
  • Countries : United States, World
World Drug and Medication: Osteosarcoma - Pipeline Review, H1 2012

World Drug and Medication: Osteosarcoma - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Osteosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Therapy
  • Countries : World
Streptococcal Infections - Pipeline Review, H1 2013

Streptococcal Infections - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

Streptococcal Infections - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Streptococcal Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Therapy
World Drug and Medication: Septic Shock - Pipeline Review, H1 2012

World Drug and Medication: Septic Shock - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Septic Shock, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Therapy
  • Countries : World, United States
Ischemic Stroke - Pipeline Review, H1 2013

Ischemic Stroke - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

Ischemic Stroke - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Ischemic Stroke - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Therapy
  • Countries : World
World Therapy: Choroidal Neovascularization - Pipeline Review, H1 2012

World Therapy: Choroidal Neovascularization - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Choroidal Neovascularization, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Therapy
  • Countries : World, United States
World Therapy: Rabies - Pipeline Review, H1 2012

World Therapy: Rabies - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Rabies, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

  • Industries : Therapy
  • Countries : Philippines, India, World, United States
World Therapy: Sarcopenia - Pipeline Review, H1 2012

World Therapy: Sarcopenia - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Sarcopenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Therapy
  • Countries : World
World Drug and Medication: Bronchopulmonary Dysplasia - Pipeline Review, H1 2012

World Drug and Medication: Bronchopulmonary Dysplasia - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Bronchopulmonary Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Therapy
  • Countries : World
H3N2 Infection - Pipeline Review, H1 2013

H3N2 Infection - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

H3N2 Infection - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'H3N2 Infection - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Therapy
  • Countries : World
Memory Impairment - Pipeline Review, H1 2013

Memory Impairment - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

Memory Impairment - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Memory Impairment - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Therapy
  • Countries : World
Percutaneous Coronary Intervention - Pipeline Review, H1 2013

Percutaneous Coronary Intervention - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

Percutaneous Coronary Intervention - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Percutaneous Coronary Intervention - Pipeline Review, H1 2013', provides an overview of the indication's ...

  • Industries : Therapy
  • Countries : World
World Drug and Medication: Thymus Cancer - Pipeline Review, H1 2012

World Drug and Medication: Thymus Cancer - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Thymus Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Therapy
  • Countries : World

» Download Public Reports

About 800 reports
Company Report: Therapy in Austria for Year 2013

Company Report: Therapy in Austria for Year 2013

  • Company report
  • March 2013
  • 8 pages

... Austron | march 2013 4 the therapy provided by medaustron medaustron will provide an innovative form of radiation therapy, namely ion beam therapy. In that process the tumours are irradiated with charged ...


» Read our Company Profiles

84 Companies

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.